作者
Canlin Yang,Yan Liu,S. J. Yao,Mi-Wen Zhang,Xiaoliang Zhang,Yi Wen
摘要
Abstract Background and Aims Acute kidney injury (AKI) is a severe syndrome with rapid kidney function decline, increasing the risk of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Macrophages are involved in acute phase of AKI and contribute to AKI-CKD transition, however the mechanisms remain unclear. The triggering receptor expressed on myeloid cells 2 (TREM2), a significant regulator within macrophages, has diverse roles in diseases, such as modulating immune responses in neurodegenerative disorders and influencing tumor microenvironments in cancer. While studies have shown TREM2 knockout worsens kidney injury after obstruction or ischemia-reperfusion injury (IRI), macrophage-specific TREM2 knockout have protective effects in the late stage of hepatic ischemia/reperfusion, highlighting the complex role of TREM2 in disease pathogenesis. Thus, elucidating the function of TREM2 in macrophages is crucial for understanding the AKI - CKD transition and identifying potential therapeutic targets. Method In-vivo and in-vitro experiments were done to study how macrophage TREM2 deficiency affects kidney repair after IRI. In-vivo, macrophage-specific TREM2 knockout (LysM-Cre+ TREM2fl/fl, TREM2 MKO) and wild-type (LysM-Cre− TREM2fl/f, WT) mice were made using CRISPR/Cas9. A unilateral renal IRI mouse model was established. Ischemic kidneys were collected at 1, 3, 7 days after AKI for histopathology, qRT-PCR to analyze kidney injury molecules, and western blot for signaling pathways. In-vitro, Raw264.7 cells had TREM2 expression reduced with lentivirus vectors. Normal and TREM2-knockdown cells were treated with LPS, and qRT-PCR measured inflammatory cytokine levels. Proteomics and RNA sequencing were used to find the underlying molecular mechanisms. Results Upon LPS induction in Raw264.7 and TREM2-kd Raw264.7 cells, compared with the normal group, the mRNA level of the inflammatory factor IL-6 was significantly decreased in TREM2-kd Raw264.7 cells (P = 0.0292), and the expression of iNOS in pro-inflammatory M1 macrophages was downregulated (P = 0.0273). In in-vivo experiments, there was no significant difference in the degree of tubular damage shown by renal pathology between MKO and WT mice after 1 and 3 days of IRI, while the renal tubular damage score was significantly lower at 7 days after IRI compared with WT mice. Genes involved in kidney injury in the kidneys demonstrated a similar pattern. Gene expression analysis showed no significant difference in the expression of renal injury-related factors between the two groups after 1 and 3 days of IRI. However, the expression of NGAL (P = 0.0090) and PAI (P = 0.0484) mRNA was down-regulated in the TREM2 MKO group after 7 days of IRI. Examination of apoptosis-related proteins Bax and Bcl2 in the IRI 7-day kidneys of TREM2 MKO and WT groups showed no differences. Proteomics and RNA sequencing analyses are currently underway. Conclusion TREM2 deficiency in macrophages promotes renal repair 7 days after renal IRI, which is inconsistent with the results of systemic TREM2 knockout. This discrepancy may be attributed to the differential effects of TREM2 in macrophages compared with other cell types. A comprehensive understanding of the role of macrophage TREM2 in the AKI-CKD transformation is essential. Currently, we are optimizing the IRI 14-day and 28-day models to further explore the role of macrophage TREM2 in this transformation. We anticipate that RNA sequencing and proteomics data will provide insights into how macrophage TREM2 exerts its renoprotective effects.